Isomorphic Labs总裁Colin Murdoch在巴黎接受Fortune采访时透露：「有人正坐在我们伦敦国王十字区的办公室里，与AI合作设计抗癌药物。 这正在发生。 」 ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

【观网财经丨智能早报 7月8日】谷歌AI制药将进行首次人体试验 Isomorphic Labs总裁兼谷歌DeepMind首席商务官Colin Murdoch透露，Isomorphic ...

• Alphabet旗下Isomorphic Labs的总裁科林·默多克（Colin Murdoch）向《财富》杂志透露，该实验室正准备启动人工智能设计药物的人体试验。这家源自DeepMind ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation. President Colin Murdoch revealed the company's ...

消息面上，Isomorphic Labs总裁兼谷歌DeepMind首席商务官Colin Murdoch透露，Isomorphic ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...